Document Detail


Diagnosis of Primary Aldosteronism in Chronic Kidney Disease by I-131 NP-59 SPECT/CT Imaging.
MedLine Citation:
PMID:  22228361     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Primary aldosteronism (PA) may be missed in patients with chronic kidney disease (CKD), because CKD may disturb the renin-angiotensin-aldosterone system. Adrenal vein sampling has increased risks in patients with CKD. We report the case of a 58-year-old man with CKD and suspected PA. Left adrenal aldosteronism was diagnosed by NP-59 SPECT/CT. Left adrenalectomy demonstrated adrenocortical nodular hyperplasia. Plasma aldosterone normalized and blood pressure stabilized after surgery. NP-59 SPECT/CT may be a helpful diagnostic tool for detecting and lateralizing PA in CKD patients.
Authors:
Yi-Chun Chen; Yu-Chieh Su; Jainn-Shiun Chiu; Chih-En Tseng
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Clinical nuclear medicine     Volume:  37     ISSN:  1536-0229     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7611109     Medline TA:  Clin Nucl Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  e30-e32     Citation Subset:  -    
Affiliation:
From the *Division of Nephrology, Department of Internal Medicine, Buddhist Dalin Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Hualien, Taiwan; †Division of Hematology-Oncology, Department of Internal Medicine, Buddhist Dalin Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Hualien, Taiwan; ‡Department of Nuclear Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua County, Taiwan; and §Department of Pathology, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is There an Optimal Scan Time for 6-[F-18]Fluoro-L-DOPA PET in Pheochromocytomas and Paragangliomas?
Next Document:  Assessment of Rhabdoid Brain Tumor by F-18 FDG PET, C-11 Methionine PET and MRI.